A nonprofit group’s Chagas drug beat out Martin Shkreli's old rival to FDA OK, valuable PRV
The FDA has approved a new drug for Chagas disease, but one of Martin Shkreli’s former biotechs — which set its sights on Chagas — isn’t the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
